A Multifaceted Evaluation of National Off-label Neurology Applications
TURKISH JOURNAL OF NEUROLOGY, cilt.26, sa.3, ss.235-241, 2020 (ESCI, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 26 Sayı: 3
- Basım Tarihi: 2020
- Doi Numarası: 10.4274/tnd.2020.37791
- Dergi Adı: TURKISH JOURNAL OF NEUROLOGY
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.235-241
- İstanbul Üniversitesi Adresli: Hayır
Özet
Objective: Off-label drug use (OLDU) of neurologic diseases is approved by a regulatory authority, the Turkish Medicines and Medical Devices Agency (TMMDA) in Turkey. It was aimed to investigate the most common neurologic drugs relevant to off-label prescribing and the most prescribed diagnosis, demographic and medical characteristics of patients with OLDU applications in Turkey.